文献速递心血管MRDSA

左心室质量独立预测接受诊断性冠状动脉造影患者的死亡率和未来血运重建需求

LV Mass Independently Predicts Mortality and Need for Future Revascularization in Patients Undergoing Diagnostic Coronary Angiography.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-07-19

研究纳入3754例接受有创冠状动脉造影和心脏磁共振的患者,中位随访44.9个月,315例(8.4%)死亡、168例(4.5%)接受血运重建。多变量分析显示左心室质量指数每增加10 g/m²,死亡风险增加6%(HR 1.06,95%CI 1.01–1.11,p=0.02),血运重建需求增加10%(HR 1.10,95%CI 1.04–1.17,p<0.01);中重度肥厚与死亡风险1.7倍(95%CI 1.2–2.3)和血运重建需求1.8倍(95%CI 1.18–2.67)相关,该关联主要见于左心室射血分数>35%者。

要点

  • 左心室质量指数是接受冠状动脉造影患者全因死亡和血运重建需求的独立预测因子。
  • 左心室质量指数每增加10 g/m²,死亡风险增加6%,血运重建需求增加10%。
  • 中重度左心室肥厚与死亡风险1.7倍、血运重建需求1.8倍相关,主要见于左心室射血分数>35%者。

核心结论

  • 左心室质量指数是全因死亡和血运重建需求的独立预测因子,该发现确立了左心室质量测量在围绕该人群血运重建需求和时机临床决策中的相关性。

研究设计与样本

  • 研究纳入3754例接受有创冠状动脉造影和心脏磁共振的患者(平均年龄59.3±13.1岁,平均间隔1.0±1.5个月),左心室质量和容积由电影图像确定并按体表面积指数化,分析校正了心脏磁共振变量、合并症和冠状动脉疾病严重程度(Duke Jeopardy评分)并按左心室功能分层。

诊断标准与关键数值

  • 左心室质量指数每增加10 g/m²,死亡风险增加6%(HR 1.06,95%CI 1.01–1.11,p=0.02),血运重建需求增加10%(HR 1.10,95%CI 1.04–1.17,p<0.01)。
  • 根据预设阈值,中重度左心室肥厚与死亡风险1.7倍(95%CI 1.2–2.3)和血运重建需求1.8倍(95%CI 1.18–2.67)相关。
  • 在左心室射血分数>35%者中,中重度左心室肥厚与死亡风险HR 2.93(95%CI 1.92–4.47)和血运重建需求HR 2.20(95%CI 1.21–3.98)相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The goal of this study was to assess associations between left ventricular (LV) mass, all-cause mortality, and need for revascularization in patients undergoing coronary angiography.

BACKGROUND: LV hypertrophy is associated with adverse cardiovascular outcomes in healthy subjects. However, its influence in those with known or suspected coronary artery disease is poorly understood.

METHODS: A total of 3,754 patients (mean age 59.3 ± 13.1 years) undergoing invasive coronary angiography and cardiac magnetic resonance (CMR) (mean interval 1.0 ± 1.5 months) were studied. LV mass and volumes were determined from cine images and indexed to body surface area. Analyses were adjusted for CMR variables, medical comorbidities, and severity of coronary artery disease (Duke Jeopardy Score) and were stratified to LV function.

RESULTS: At a median of 44.9 months, 315 patients (8.4%) died and 168 patients (4.5%) underwent revascularization. Multivariable analysis showed that each 10 g/m2 increase in LV mass index was associated with a 6% greater risk of mortality (hazard ratio: 1.06; 95% confidence interval [CI]: 1.01 to 1.11; p = 0.02) and a 10% greater need for revascularization (hazard ratio: 1.10; 95% CI: 1.04 to 1.17; p < 0.01). According to pre-defined thresholds, moderate to severe hypertrophy was associated with a 1.7-fold risk of mortality (95% CI: 1.2 to 2.3) and 1.8-fold need for revascularization (95% CI: 1.18 to 2.67). These findings were predominantly observed in those with a left ventricular ejection fraction >35% with respective hazard ratios of 2.93 (95% CI: 1.92 to 4.47) and 2.20 (95% CI: 1.21 to 3.98).

CONCLUSIONS: LV mass index is an independent predictor of all-cause mortality and need for revascularization. This finding establishes relevance for LV mass measurements in clinical decision-making surrounding both the need and timing of revascularization in this population.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Abdi-Ali A, Miller RJH, Southern D, et al. LV Mass Independently Predicts Mortality and Need for Future Revascularization in Patients Undergoing Diagnostic Coronary Angiography. JACC Cardiovasc Imaging. 2017. PMID: 28734928. doi:10.1016/j.jcmg.2017.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。